Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $78.50, giving the company a market capitalization of 8.39B. It carries a P/E multiple of 221.40.
On 2026-06-11, Corcept Therapeutics(CORT) stock moved within a range of $76.52 to $81.91. With shares now at $78.50, the stock is trading +2.6% above its intraday low and -4.2% below the session's peak.
Trading volume for Corcept Therapeutics(CORT) stock has reached 1.49M, versus its average volume of 989.76K.
The stock's 52-week range extends from a low of $28.66 to a high of $91.00.
The stock's 52-week range extends from a low of $28.66 to a high of $91.00.
CORT News
...
In late May and early June 2026, Corcept Therapeutics reported strong overall survival data for newly approved ovarian cancer drug Lifyorli from its Phase 3 ROS...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.